What is Varithena?
Varithena is an FDA-approved chemical ablation treatment option for trunk vein reflux. The Varithena microfoam solution is prepared to produce a consistent foam for injection. The foam state of the sclerotherapy medication improves its effectiveness for closing the vein. As with all ablations, the goal is to close the trunk vein that is refluxing. This should improve the symptoms of venous incompetence and prevent progression of disease. This form of treatment does not require local anesthesia to prepare the vein. Sclerotherapy of large veins may produce pigmentation and phlebitis of the skin.
How does it work?
During this procedure, foam sclerosant will be injected into the target vein using a small catheter. The Varithena microfoam fills the section of the vein being treated and causes a chemical injury to the wall of the vein resulting in contraction of the vein and eventual closure. Blood flow will shift to healthier veins as a result.
What should I expect after the procedure?
Our doctors will determine if you are a good candidate for this method. Varithena is virtually pain free and requires only minimal local anesthetic at the injection site. Recovery time is minimal and most activities can be resumed the same day. Patients must wear compression hose for 3 days after treatment. As with all vein treatments, there is a risk of blood clots with the use of sclerosant. The cosmetic outcome of Varithena may not be as certain as with phlebectomy.
Why Capitol Vein & Laser Centers?
Drs. Rosenberg and McNeill were primary investigators on the Phase III FDA approved clinical study assessing efficacy of Varithena in treating varicose veins. Patients should be encouraged to seek evaluation and treatment to restore normal leg vascular health and avoid potential serious complications.
